ARK Investment Management LLC 13D and 13G filings for Verve Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-10 9:24 pm Sale |
2024-09-30 | 13G | Verve Therapeutics, Inc. VERV |
ARK Investment Management LLC | 0 0.000% |
-7,025,116 (Position Closed) |
Filing |
| 2024-01-29 4:00 pm Purchase |
2023-12-31 | 13G | Verve Therapeutics, Inc. VERV |
ARK Investment Management LLC | 7,025,116 8.740% |
2,659,286 (+60.91%) |
Filing |
| 2023-02-10 2:33 pm Purchase |
2022-12-31 | 13G | Verve Therapeutics, Inc. VERV |
ARK Investment Management LLC | 4,365,830 7.090% |
4,365,830 (New Position) |
Filing |